NCT03784274

Brief Summary

In Pakistan, numerous policies have been formulated in the past on pneumonia management translated into various programs. However, despite completion, the state of pneumonia mortality remains unchanged as no sustainable solutions have been yielded by these programs. This is probably because there was no ownership of these policies and programs at the provincial, district and community level. We, therefore, plan to understand pneumonia related policy environment within Pakistan to identify gaps in this system through a two phased study. The first will be qualitative with key informant interviews conducted from relevant stakeholders, e.g, policy makers, practitioners, academicians, researchers etc., to understand how policies are conceptualized. Data will be analyzed through an integrated approach in a software. The second phase will social network research conducted by studying actors linked together by social relations. This will be achieved through net mapping exercise to understand, discuss, and visualize how various actors influence pneumonia related outcomes through technical and financial links. Data will be analyzed through the Organizational Risk Analyzer (ORA) which is a meta-network assessment and analysis tool. This study will be the first of its kind for under-five pneumonia and will guide policy makers for creating effective solutions to combat the disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 21, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

June 10, 2024

Status Verified

June 1, 2024

Enrollment Period

1.7 years

First QC Date

November 26, 2018

Last Update Submit

June 7, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Identification of Pneumonia Policy Formation in Pakistan

    To identify and analyse pneumonia related policies/strategies in Pakistan for children under five. A matrix would be developed to assess all relevant national and governmental policies related to pediatric pneumonia in Pakistan. Descriptive content analysis would be conducted for national policies on acute respiratory illness (both federal and provincial).

    12 months

  • Facilitators and barriers for under five pneumonia related policy development and implementation

    In depth interviews of key stakeholders will be conducted to assess the facilitators and barriers to under five pneumonia related policy development and implementation.

    6 months

Study Arms (1)

Stakeholders

Key stakeholders involved program and policy making

Behavioral: Stakeholder analysis

Interventions

• INCLUSION CRITERIA FOR NET MAPPING ACTIVITIES: Those respondents who are directly involved or knowledgeable about pneumonia related policy environment in the country/province. * Respondents who consent to participate in the study. * Respondents belonging to Sindh, Punjab, Baluchistan, KPK and Islamabad. EXCLUSION CRITERIA: • Respondents belonging to Gilgit-Baltistan (GB), Azad Jammu and Kashmir (AJK) and Federally Administered Tribal Area (FATA). Reasons of their exclusion are newly developed governance system (GB), separate governance (AJK) and security threat (FATA).

Stakeholders

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

For the qualitative phase of interviews and focus group discussions, purposeful sampling will be employed and the sample size will be based on the point of theoretical saturation, although at least 20 interviews will be conducted (4 in each of the five administrative divisions; Punjab, Sindh, Baluchistan, KPK and Federal capital). The type of respondents for the in depth interviews would be policy makers, program managers, project coordinators (national or provincial), academicians, researchers, practitioners etc.

You may qualify if:

  • Those respondents who are directly involved or knowledgeable about pneumonia related policy environment in the country/province.
  • Respondents who consent to participate in the study.
  • Respondents belonging to Sindh, Punjab, Baluchistan, KPK and Islamabad.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternal, Neonatal and Child Health Research Netork

Islamabad, Federal, 44000, Pakistan

Location

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Dr Tabish Hazir, MBBS, FRCPCH

    Maternal, Neonatal and Child Health Research Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2018

First Posted

December 21, 2018

Study Start

May 1, 2018

Primary Completion

January 1, 2020

Study Completion

April 30, 2020

Last Updated

June 10, 2024

Record last verified: 2024-06

Locations